Enthera Pharmaceuticals is rated 3 out of 5 in the category first-in-class therapeutics for autoimmune disorders. Read and write reviews about Enthera Pharmaceuticals. We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases
Company size
1-10 employees
Headquarters
Milan, Lombardy